Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpheart.00949.2007PMID 18203848
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin-deficient diabetes.

  2007cited by this paper
• AMPK and metabolic adaptation by the heart to pressure overload.

  2007cited by this paper
• Cardiac Metabolism and Mechanics are Altered by Genetic Loss of Lipoprotein Triglyceride Lipolysis

  2006cited by this paper
• The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus.

  2005cited by this paper
• Selective versus nonselective β‐adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization

  2005cited by this paper
• Fatty acid metabolism is enhanced in type 2 diabetic hearts.

  2005cited by this paper
• Phosphorylation of Rat Liver Mitochondrial Carnitine Palmitoyltransferase-I

  2004cited by this paper
• Functional coupling as a basic mechanism of feedback regulation of cardiac energy metabolism

  2004cited by this paper
• Altered cardiac calcium handling in diabetes

  2004cited by this paper
• Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.

  2003cited by this paper
• Expression, purification, and reconstitution of rat liver carnitine palmitoyltransferase I.

  2003cited by this paper
• Ketones: metabolism's ugly duckling.

  2003cited by this paper
• Atrophic Remodeling of the Heart In Vivo Simultaneously Activates Pathways of Protein Synthesis and Degradation

  2003cited by this paper
• What Is the Role of &bgr;-Adrenergic Signaling in Heart Failure?

  2003cited by this paper
• Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions

  2002cited by this paper
• Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts.

  2002cited by this paper
• Malonyl CoA control of fatty acid oxidation in the ischemic heart.

  2002cited by this paper
• Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.

  2002cited by this paper
• Long-term endothelin receptor blockade improves cardiovascular function in diabetes.

  2001cited by this paper
• Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia.

  2000cited by this paper
• Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin.

  2000cited by this paper
• Sarcoplasmic reticulum function and carnitine palmitoyltransferase‐1 inhibition during progression of heart failure

  2000cited by this paper
• Diabetic cardiomyopathy and carnitine deficiency.

  1999cited by this paper
• Multiple-site phosphorylation of the 280 kDa isoform of acetyl-CoA carboxylase in rat cardiac myocytes: evidence that cAMP-dependent protein kinase mediates effects of beta-adrenergic stimulation.

  1999cited by this paper
• Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

  1999cited by this paper
• Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats.

  1999cited by this paper
• Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol.

  1998cited by this paper
• Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation.

  1998cited by this paper
• Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure.

  1998cited by this paper
• Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation.

  1998cited by this paper
• Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapy.

  1998cited by this paper
• Etomoxir improves left ventricular performance of pressure-overloaded rat heart.

  1997cited by this paper
• Comparison of different fixed antihypertensive combination drugs: a double‐blind, placebo‐controlled parallel group study

  1997cited by this paper
• Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels.

  1996cited by this paper
• Ischemia and reperfusion injury in the hypertrophied heart.

  1996cited by this paper
• Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts.

  1994cited by this paper
• Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study.

  1994cited by this paper
• Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system.

  1992cited by this paper
• Rapid determination of creatine, phosphocreatine, purine bases and nucleotides (ATP, ADP, AMP, GTP, GDP) in heart biopsies by gradient ion-pair reversed-phase liquid chromatography.

  1992cited by this paper
• Polyol pathway‐mediated changes in cardiac muscle contractile properties: studies in streptozotocin‐diabetic and galactose‐fed rats

  1992cited by this paper
• A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

  1991cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• Determination of short-chain coenzyme A compounds by reversed-phase high-performance liquid chromatography.

  1988cited by this paper
• Effect of myo-Inositol and T3 on Myocardial Lipids and Cardiac Function in Streptozocin-Induced Diabetic Rats

  1988cited by this paper
• Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

  1987cited by this paper
• The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance.

  1982cited by this paper
• Diabetogenic action of streptozotocin: relationship of dose to metabolic response.

  1969cited by this paper
• Regulation of glucose uptake by muscles. 10. Effects of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, and of fatty acids, ketone bodies and pyruvate, on the glycerol output and concentrations of free fatty acids, long-chain fatty acyl-coenzyme A, glycerol phosphate and citrate-cycl

  1964cited by this paper
• Regulation of Glucose Uptake by Muscle

  1962cited by this paper
• Myocardial metabolism of fatty acids.

  1960cited by this paper

• Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction

  2024cites this paper
• Recent Advances Associated with Cardiometabolic Remodeling in Diabetes-induced Heart Failure.

  2024cites this paper
• Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation

  2024cites this paper
• Direct expression of CPT1a enables a high throughput platform for the discovery of CPT1a modulators

  2024cites this paper
• The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy

  2023cites this paper
• Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling

  2023cites this paper
• Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions

  2023cites this paper
• Integrating population-level and cell-based signatures for drug repositioning

  2023cites this paper
• A Mini Review of Small-Molecule Inhibitors Targeting Palmitoyltransferases

  2022cites this paper
• Heart Failure and Drug Therapies: A Metabolic Review

  2022cites this paper
• Metabonomic Characteristics of Myocardial Diastolic Dysfunction in Type 2 Diabetic Cardiomyopathy Patients

  2022cites this paper
• Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure

  2021cites this paper
• Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease?

  2021cites this paper
• Structural and Functional Remodeling of Mitochondria in Cardiac Diseases

  2021influential citation
• Intracellular ATP Concentration and Implication for Cellular Evolution

  2021cites this paper
• The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity

  2021cites this paper
• Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy

  2021cites this paper
• Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway

  2019cites this paper
• Metabolomic analysis and biochemical changes in the urine and serum of streptozotocin-induced normal- and obese-diabetic rats

  2018cites this paper
• Regulating microRNA expression: at the heart of diabetes mellitus and the mitochondrion.

  2018cites this paper
• Features of pharmacotherapy β1- adrenoblocker with activation of endothelial nitric oxide nebivolol in patients with coronary heart disease on the background of chronic heart failure (review of literature)

  2018cites this paper
• Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction

  2017cites this paper
• Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target

  2017cites this paper
• Glucose Metabolism in Cancer and Ischemia: Possible Therapeutic Consequences of the Warburg Effect

  2017cites this paper
• PPARβ/δ and lipid metabolism in the heart.

  2016cites this paper
• Nutrient sensing and utilization: Getting to the heart of metabolic flexibility.

  2016cites this paper
• Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.

  2016cites this paper
• Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade

  2016cites this paper
• Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

  2016cites this paper
• Deranged Cardiac Metabolism and the Pathogenesis of Heart Failure.

  2015cites this paper
• Insulin therapy normalizes reduced myocardial β-adrenoceptors at both the onset and after sustained hyperglycemia in diabetic rats.

  2015cites this paper
• Adrenergic Control of Cardiac Fatty Acid Oxidation in Diabetes

  2014cites this paper
• Regulation of crp Gene Expression by the Catabolite Repressor/Activator, Cra, in Escherichia coli

  2014cites this paper
• Modulation of Myocardial Metabolism by 3-Ketoacyl Coenzyme a Thiolase Inhibition and Other Agents in Heart Failure Treatment

  2014cites this paper
• Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy

  2014influential citation
• Combined metoprolol and ascorbic acid treatment prevents intrinsic damage to the heart during diabetic cardiomyopathy.

  2014cites this paper
• Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy

  2014cites this paper
• Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management.

  2013cites this paper
• Protective effects of metoprolol and ascorbic acid during the development of diabetic cardiomyopathy

  2012cites this paper
• Antiischemic effects of metoprolol and the risk of carbohydrate metabolism disturbances in angina patients

  2012cites this paper
• Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.

  2012cites this paper
• Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells.

  2012cites this paper
• Nebivolol: impact on cardiac and endothelial function and clinical utility

  2012cites this paper
• Pro-apoptotic effect of anti-β1-adrenergic receptor antibodies in periodontitis patients.

  2012cites this paper
• Diabetic Cardiomyopathy: Cardiac Changes, Pathophysiological Mechanisms, Biologic Markers, and the Available Therapeutic Armamentarium

  2012cites this paper
• Reduced CGP12177 binding to cardiac β-adrenoceptors in hyperglycemic high-fat-diet-fed, streptozotocin-induced diabetic rats.

  2011cites this paper
• β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions.

  2011cites this paper
• Cardioprotective effect of propranolol on diabetes-induced altered intracellular Ca2+ signaling in rat

  2011cites this paper
• Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts.

  2011cites this paper
• Post-translational modifications of mitochondrial outer membrane proteins

  2011influential citation
• Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze.

  2011cites this paper
• working hearts normoxic metabolic fluxes and energy status of healthy Ivabradine reduces heart rate while preserving

  2011cites this paper
• Cardiac Dysfunction and Metabolism: Unravelling the Molecular Cross-Talk

  2011cites this paper
• Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia

  2011cites this paper
• Impact fonctionnel et métabolique d’une réduction de la fréquence cardiaque induite par un inhibiteur du courant If, l’ivabradine : approche expérimentale chez le porc et la souris

  2010cites this paper
• Functional effects of protein kinases and peroxynitrite on cardiac carnitine palmitoyltransferase-1 in isolated mitochondria

  2010cites this paper
• ^1H NMR-based Metabonomic Analysis of Metabolic Changes in Streptozotocin-induced Diabetic Rats

  2010cites this paper
• Mitochondria in heart failure.

  2010cites this paper
• Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes.

  2009cites this paper
• The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.

  2009cites this paper
• Metoprolol represses PGC1alpha-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart.

  2009cites this paper
• Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice

  2009cites this paper
• Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?

  2009cites this paper
• Effects of metabolic approach in diabetic patients with coronary artery disease.

  2009cites this paper
• To scale or not to scale: the principles of dose extrapolation

  2009cites this paper
• Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers.

  2009cites this paper
• Heart rate reduction is probably not the main beneficial mechanism by which beta blockade improves outcome in patients with systolic chronic heart failure.

  2008cites this paper
• Metabolic therapy of heart failure.

  2008cites this paper
• Dofetilide for the Prevention of Postoperative Atrial Fibrillation After Coronary Surgery: Is It a Useful Routine Prophylaxis? We read with great interest the report

  2008cites this paper
• Metoprolol increases the expression of beta(3)-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3.

  2008cites this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper